Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer

Annals of Nuclear Medicine

Volumn 28, Issue 1, 2014, Pages 17-24

  Tan, Hui ^a,b   Jiang, Lei ^a,b   Gu, Yusen ^a,b   Xiu, Yan ^a,b   Han, Lei ^a,b   Wu, Pengyue ^a,b   Zhang, Hongwei ^a   Shi, Hongcheng ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MEDICAL IMAGING   (China)

Author keywords

Breast cancer; Breast specific gamma imaging (BSGI); Dual phase; Primary

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST LESION; BREAST PAPILLOMA; CANCER DIAGNOSIS; COMPARATIVE STUDY; CYSTOSARCOMA PHYLLOIDES; DUAL PHASE BREAST SPECIFIC GAMMA IMAGING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GAMMA RAYS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; ORGAN SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 84893163984     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0776-7     Document Type: Article

References (19)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-84.
3. Rosenberg RD, Hunt WC, Williamson M, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511-8.
4. Kolb T, Lichy J, Newhuose J. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27, 825 patient evaluations. Radiology. 2002;225:167-75.
5. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-49.
6. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151-63.
7. Kim IJ, Kim YK, Kim SJ. Detection and prediction of breast cancer using double phase 99Tcm-MIBI scintimammography in comparison with MRI. Onkologie. 2009;32:556-60.
8. Arslan N, Oztürk E, Ilgan S, Urhan M, Karaçalioglu O, Pekcan M, et al. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun. 1999;20:317-25.
9. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med. 1996;23:940-6.
10. Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, et al. SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol. 2010;38:219-24.
11. Weigert JM, Bertrand ML, Lanzkowsky L, Stern LH, Kieper DA. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. Am J Roentgenol. 2012;198:W69-75.
12. Lee A, Chang J, Lim W, Kim BS, Lee JE, Cha ES, et al. Effectiveness of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer in Korea: a comparative study. Breast J. 2012;18:453-8.
13. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, et al. Double-phase 99Tcm-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med. 1999;40:376-80.
14. Arslan N, Ozturk E, Ilgan S, Narin Y, Dundar S, Tufan T, et al. The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report. Ann Nucl Med. 2000;14:39-46.
15. Paz A, Melloul M, Cytron S, Koren R, Ohana G, Michalevich D, et al. The value of early and double phase 99mTc-sestamibi scintimammography in the diagnosis of breast cancer. Nucl Med Commun. 2000;21:341-8.
16. Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Eur J Radiol. 2005;53:192-8.
17. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995;36:1758-65.
18. Lu G, Shih WJ, Huang HY, Long MQ, Sun Q, Liu YH, et al. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging. Nucl Med Commun. 1995;16:150-60.
19. Del VS, Salvatore M. 99Tcm-MIBI in the evaluation of breast cancer biology. Eur J Nucl Med Mol Imaging. 2004;31:S88-96.